Hearing News Watch

Featured image for “Apple Hearing Study Unveils New Insights on Tinnitus in Landmark Survey”
May. 28, 2024

Apple Hearing Study Unveils New Insights on Tinnitus in Landmark Survey

HHTM
Apple, in collaboration with the University of Michigan, has released groundbreaking findings from the Apple Hearing Study, shedding light on tinnitus in one of the largest surveys to date. The study, which reviewed responses from over 160,000 participants, aims to improve the understanding of tinnitus characteristics and inform future research on potential treatments. Prevalence and Impact of Tinnitus The study’s
Featured image for “New Study: Hearing Loss Increases Risk of Cognitive Impairment, Dementia, and Alzheimer’s Disease”
May. 27, 2024

New Study: Hearing Loss Increases Risk of Cognitive Impairment, Dementia, and Alzheimer’s Disease

HHTM
A new systematic review and meta-analysis published in Ageing Research Reviews examined the relationship between adult-onset hearing loss and cognitive impairment. Analyzing data from fifty cohort studies involving over 1.5 million participants, the study suggests that hearing loss significantly increases the risk of cognitive decline, dementia, and Alzheimer’s disease (AD). Hearing loss is a major global health issue affecting an
Featured image for “New Study Highlights Tamiflu as a Promising Otoprotective Drug”
May. 25, 2024

New Study Highlights Tamiflu as a Promising Otoprotective Drug

HHTM
In a recent pre-print study posted on bioRxiv, researchers have identified oseltamivir, commonly known by its brand name Tamiflu®, as a potential otoprotective therapeutic candidate. The study highlights oseltamivir’s protective effects against hearing loss induced by both cisplatin chemotherapy and traumatic noise exposure. Currently, sodium thiosulfate (STS) is the only FDA-approved drug available to prevent hearing loss, specifically for use
Featured image for “Study Reveals High Incidence of Vestibular Impairment in Children with Profound Hearing Loss, Impacting Development”
May. 24, 2024

Study Reveals High Incidence of Vestibular Impairment in Children with Profound Hearing Loss, Impacting Development

HHTM
A recent cohort study published today in JAMA Network Open has revealed significant findings on the prevalence of vestibular impairment in children with bilateral profound hearing loss (HL) and its association with developmental delays. Conducted by Dr. Sylvette R. Wiener-Vacher and her colleagues at a pediatric referral center in Paris, France, the study underscores the critical need for comprehensive vestibular
Featured image for “Cilcare Appoints Dr. Naimi Missoum as Chief Medical Officer”
May. 23, 2024

Cilcare Appoints Dr. Naimi Missoum as Chief Medical Officer

HHTM
MONTPELLIER, FRANCE – Cilcare, a clinical-stage biotechnology company specializing in auditory sciences and the development of novel therapies for inner ear diseases, has announced the appointment of Dr. Naimi Missoum as Chief Medical Officer. Dr. Missoum, a Medical Doctor with over 25 years of experience as a senior executive in medical affairs at leading pharmaceutical companies, will oversee all of
Featured image for “Ear Science Institute Australia Secures Funding to Develop Australasian Biobank for Genetic Hearing Loss”
May. 22, 2024

Ear Science Institute Australia Secures Funding to Develop Australasian Biobank for Genetic Hearing Loss

HHTM
Ear Science Institute Australia has secured Future Health Research & Innovation (FHRI) funding to establish a Western Australia-headquartered Australasian biobank, aimed at advancing genetic therapies for childhood and adult hearing loss. The Australasian Hearing Registry and Biobank (AHRB) will be the first in Australia to store tissue related to genetic-associated hearing loss, with the goal of advancing personalized care and
Featured image for “Sound Pharmaceuticals Receives FDA Clearance for Phase 2 Trial of SPI-1005 in Cochlear Implant Patients”
May. 20, 2024

Sound Pharmaceuticals Receives FDA Clearance for Phase 2 Trial of SPI-1005 in Cochlear Implant Patients

HHTM
SEATTLE & INNSBRUCK, AUSTRIA — Sound Pharmaceuticals (SPI) has announced that it has received FDA notification that its Investigational New Drug Application (IND) may proceed involving SPI-1005 treatment and cochlear implantation (CI). The goal of this Phase 2 SPI-1005 (ebselen) trial is to reduce the loss of residual hearing during and after CI. Ebselen is a novel anti-inflammatory compound that
Featured image for “Rock Legend Paul Gilbert Named Phonak Global Brand Ambassador”
May. 16, 2024

Rock Legend Paul Gilbert Named Phonak Global Brand Ambassador

HHTM
STAFA, SWITZERLAND – Phonak, a leading global provider of hearing solutions, has announced legendary guitarist Paul Gilbert as its official Global Brand Ambassador. In this role, Gilbert will focus on raising awareness about hearing health, challenging stigmas associated with hearing loss, and emphasizing the importance of hearing devices. Gilbert, the co-founder of the iconic rock band Mr. Big known for
Featured image for “BHP Partners with Ear Science Institute Australia on Hearing Health Program for Indigenous Communities”
May. 16, 2024

BHP Partners with Ear Science Institute Australia on Hearing Health Program for Indigenous Communities

HHTM
BHP has become the newest philanthropic partner for the Ear Science Institute Australia’s Gift of Hearing Appeal, providing $825,000 in funding to support the institute’s Healthy Hearing Outback program. This collaboration aims to enhance ear and hearing health outcomes for Aboriginal families in the East Pilbara region of Western Australia. In close cooperation with the Puntukurnu Aboriginal Medical Service (PAMS),
Featured image for “ReSound “Gift of Hearing” donation campaign surpasses 1,000 hearing aid recipient milestone”
May. 16, 2024

ReSound “Gift of Hearing” donation campaign surpasses 1,000 hearing aid recipient milestone

HHTM
BLOOMINGTON, MINNESOTA – With the help of 260 hearing care practices throughout the United States and Canada, ReSound today announces that 661 hearing aids were donated to 331 people as part of the annual Gift of Hearing campaign that ran December 2023 through April 2024. This was the first year that Canada participated in the campaign. The Gift of Hearing